Xichen Lian

According to our database, Xichen Lian authored at least 6 papers between 2021 and 2022.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of four.

2022

Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents.

Ying Zhou, Yintao Zhang, Xichen Lian, Fengcheng Li, Chaoxin Wang, Feng Zhu, Yunqing Qiu, Yuzong Chen

Nucleic Acids Res., 2022

SYNBIP: synthetic binding proteins for research, diagnosis and therapy.

Xiaona Wang, Fengcheng Li, Wenqi Qiu, Binbin Xu, Yanlin Li, Xichen Lian, Hongyan Yu, Zhao Zhang, Jianxin Wang, Zhaorong Li, Weiwei Xue, Feng Zhu

Nucleic Acids Res., 2022

NPCDR: natural product-based drug combination and its disease-specific molecular regulation.

Xueni Sun, Yintao Zhang, Ying Zhou, Xichen Lian, Lili Yan, Ting Pan, Ting Jin, Han Xie, Zimao Liang, Wenqi Qiu, Jianxin Wang, Zhaorong Li, Feng Zhu, Xinbing Sui

Nucleic Acids Res., 2022

Biological activities of drug inactive ingredients.

Chenyang Zhang, Minjie Mou, Ying Zhou, Wei Zhang, Xichen Lian, Shuiyang Shi, Mingkun Lu, Huaicheng Sun, Fengcheng Li, Yunxia Wang, Zhenyu Zeng, Zhaorong Li, Bing Zhang, Yunqing Qiu, Feng Zhu, Jianqing Gao

Briefings Bioinform., 2022

2021

The miRNA: a small but powerful RNA for COVID-19.

Song Zhang, Kuerbannisha Amahong, Xiuna Sun, Xichen Lian, Jin Liu, Huaicheng Sun, Yan Lou, Feng Zhu, Yunqing Qiu

Briefings Bioinform., 2021

Pharmacometabonomics: data processing and statistical analysis.

Jianbo Fu, Ying Zhang, Jin Liu, Xichen Lian, Jing Tang, Feng Zhu

Briefings Bioinform., 2021